4.7 Article

The Impact of Cardiac Radiation Dosimetry on Survival After Radiation Therapy for Non-Small Cell Lung Cancer

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ijrobp.2017.04.026

Keywords

-

Funding

  1. Medical Research Council Grant [MC_PC_12001/2]
  2. Cancer research UK [C13530/A10424, CDF 17203]
  3. Cancer Research UK [17007, 8313] Funding Source: researchfish
  4. Medical Research Council [MC_PC_12001/2] Funding Source: researchfish
  5. MRC [MC_PC_12001/2] Funding Source: UKRI

Ask authors/readers for more resources

Purpose: The heart receives high radiation doses during radiation therapy of advanced-stage lung cancer. We have explored associations between overall survival, cardiac radiation doses, and electrocardiographic (ECG) changes in patients treated in IDEAL-CRT, a trial of isotoxically escalated concurrent chemoradiation delivering tumor doses of 63 to 73 Gy. Methods and Materials: Dosimetric and survival data were analyzed for 78 patients. The whole heart, pericardium, AV node, and walls of left and right atria (LA/RA-Wall) and ventricles (LV/RV-Wall) were outlined on radiation therapy planning scans, and differential dose-volume histograms (dDVHs) were calculated. For each structure, dDVHs were approximated using the average dDVH and the 10 highest-ranked structure-specific principal components (PCs). ECGs at baseline and 6 months after radiation therapy were analyzed for 53 patients, dichotomizing patients according to presence or absence of any ECG change (conduction or ischemic/pericarditis-like change). All-cause death rate (DR) was analyzed from the start of treatment using Cox regression. Results: 38% of patients had ECG changes at 6 months. On univariable analysis, higher scores for LA-Wall-PC6, Heart-PC6, any ECG change, and larger planning target volume (PTV) were significantly associated with higher DR (PZ. 003,.009,.029, and.037, respectively). Heart-PC6 and LA-Wall-PC6 represent larger volumes of whole heart and left atrial wall receiving 63 to 69 Gy. Cardiac doses >= 63 Gy were concentrated in the LA-Wall, and consequently Heart-PC6 was highly correlated with LA-Wall-PC6. Any ECG change,LA-Wall-PC6 scores, and PTV size were retained in the multivariable model. Conclusions: We found associations between higher DR and conduction or ischemic/pericarditis-like changes on ECG at 6 months, and between higher DR and higher Heart-PC6 or LA-Wall-PC6 scores, which are closely related to heart or left atrial wall volumes receiving 63 to 69 Gy in this small cohort of patients. Crown Copyright (C) 2017 Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging System

Matt Lechner, Yoko Takahashi, Mario Turri-Zanoni, Marco Ferrari, Jacklyn Liu, Nicholas Counsell, Davide Mattavelli, Vittorio Rampinelli, William Vermi, Davide Lombardi, Rami Saade, Ki Wan Park, Volker H. Schartinger, Alessandro Franchi, Carla Facco, Fausto Sessa, Simonetta Battocchio, Tim R. Fenton, Francis M. Vaz, Paul O'Flynn, David Howard, Paul Stimpson, Simon Wang, S. Alam Hannan, Samit Unadkat, Jonathan Hughes, Raghav Dwivedi, Cillian T. Forde, Premjit Randhawa, Simon Gane, Jonathan Joseph, Peter J. Andrews, Manas Dave, Jason C. Fleming, David Thomson, Tianyu Zhu, Andrew Teschendorff, Gary Royle, Christopher Steele, Joaquin E. Jimenez, Jan Laco, Eric W. Wang, Carl Snyderman, Peter D. Lacy, Robbie Woods, James P. O'Neill, Anirudh Saraswathula, Raman Preet Kaur, Tianna Zhao, Murugappan Ramanathan, Gary L. Gallia, Nyall R. London, Quynh-Thu Le, Robert B. West, Zara M. Patel, Jayakar V. Nayak, Peter H. Hwang, Mario Hermsen, Jose Llorente, Fabio Facchetti, Piero Nicolai, Paolo Bossi, Paolo Castelnuovo, Amrita Jay, Dawn Carnell, Martin D. Forster, Diana M. Bell, Valerie J. Lund, Ehab Y. Hanna

Summary: This study retrospectively analyzed clinical data from 505 cases of sinonasal mucosal melanoma (SNMM). It found that further stratifying the T3 stage by sinus involvement has a high predictive value for prognosis. Adjuvant radiotherapy can improve survival rates, and immune checkpoint inhibitors show potential benefits for the treatment of recurrent, persistent, or metastatic disease.

JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE (2023)

Review Oncology

Study protocol for the OligoMetastatic Esophagogastric Cancer (OMEC) project: A multidisciplinary European consensus project on the definition and treatment for oligometastatic esophagogastric cancer

Tiuri E. Kroese, Peter S. N. van Rossum, Magnus Nilsson, Florian Lordick, Elizabeth C. Smyth, Riccardo Rosati, Philippe Nafteux, Domenico D'Ugo, M. Asif Chaudry, Wojciech Polkowkski, Franco Roviello, Ines Gockel, Piotr Kolodziejczyk, Karin Haustermans, Matthias Guckenberger, Marianne Nordsmark, Maria A. Hawkins, Andres Cervantes, Tania Fleitas, Eric van Cutsem, Markus Moehler, Anna D. Wagner, Hanneke W. M. van Laarhoven, Richard van Hillegersberg

Summary: Currently, there is a lack of uniform definition and treatment for oligometastatic esophagogastric cancer. The OligoMetastatic Esophagogastric Cancer (OMEC) project aims to develop a multidisciplinary European consensus statement to improve outcomes for these patients.
Letter Otorhinolaryngology

The burden of olfactory dysfunction during the COVID-19 pandemic in the United Kingdom

Matt Lechner, Jacklyn Liu, Nicholas Counsell, David Gillespie, Deepak Chandrasekharan, Ngan Hong Ta, Kiran Jumani, Raj Gupta, John Rocke, Claire Williams, Abigail Tetteh, Rajesh Amnolsingh, Sadie Khwaja, Rachel L. Batterham, Carol H. Yan, Thomas A. Treibel, James C. Moon, Jane Woods, Ria Brunton, Jim Boardman, Matthew Hatter, Mohamed Abdelwahab, F. Christopher Holsinger, Robson Capasso, Jayakar V. Nayak, Peter H. Hwang, Zara M. Patel, Santdeep Paun, Nicholas Eynon-Lewis, B. Nirmal Kumar, Samuel Jayaraj, Claire Hopkins, Carl Philpott, Valerie J. Lund

RHINOLOGY (2023)

Article Hematology

Relapse patterns in early-PET negative, limited-stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy-a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials

Valeria Fiaccadori, Anouk Neven, Catherine Fortpied, Igor Aurer, Marc Andre, Massimo Federico, Nicholas Counsell, Elizabeth H. Phillips, Laura Clifton-Hadley, Sally F. Barrington, Timothy Illidge, John Radford, John M. M. Raemaekers

Summary: The H10 and RAPID trials compared combined modality treatment (CMT) with chemotherapy (C) in limited-stage Hodgkin lymphoma (HL) with negative early positron emission tomography (ePETneg). The results showed that omitting radiotherapy (RT) in ePETneg HL resulted in more early relapses, while RT significantly reduced the risk of early relapses in both trials.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Article Oncology

Refining adjuvant treatment in endometrial cancer based on molecular features: the RAINBO clinical trial program

T. Bosse, C. L. Creutzberg, E. J. Crosbie, K. Han, N. Horeweg, A. Leary, J. R. Kroep, J. N. McAlpine, M. E. Powell, F. Blanc-Durand, M. de Bruyn, D. N. Church, V. H. Koelzer, S. Kommoss, N. Singh, A. Bardet, N. Counsell, H. Putter, D. Tu, R. Edmondson, C. Gordon, J. Ledermann, P. Morice, H. MacKay, H. Nijman, R. A. Nout, V. T. H. B. M. Smit, H. White, J. Alexandre, S. M. de Boer, I Boere, R. Cooper, J. L. Ethier, J. S. Frenel, J. McGrane, A. Taylor, S. Welch, A. M. Westermann, H. Dijcker-van der Linden, L. Farrelly, A. Feeney, M. Kaya, W. Liu, A. Melis, F. Ngadjeua-Tchouatieu, W. Parulekar, K. Verhoeven-Adema, RAINBO Res Consortium

Summary: The RAINBO program aims to investigate molecular class-directed adjuvant treatment strategies for endometrial cancer, with the goal of improving clinical outcomes and reducing toxicity. It consists of four international clinical trials and an overarching research program to advance knowledge of predictive and prognostic markers.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2023)

Letter Otorhinolaryngology

High prevalence of persistent smell loss and qualitative smell dysfunction during the coronavirus disease 2019 (COVID-19) pandemic in the United States: Urgent need for clinical trials

Matt Lechner, Jacklyn Liu, Nicholas Counsell, Carol. H. H. Yan, Santdeep Paun, Nicholas Eynon-Lewis, Liam Sutton, Samuel Jayaraj, Rachel L. Batterham, Claire Hopkins, Carl Philpott, Valerie J. Lund, Matthew Hatter, Mohamed Abdelwahab, F. Christopher Holsinger, Robson Capasso, Jayakar. V. V. Nayak, Peter. H. H. Hwang, Zara. M. M. Patel

INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY (2023)

Article Oncology

Differential Response of Pelvic Bone Marrow Fluorodeoxyglucose Uptake in Patients Receiving Concurrent Chemoradiotherapy

M. Robinson, R. Muirhead, D. R. Mcgowan, K. -Y. Chu, C. Jacobs, M. A. Hawkins

Summary: The definition of active pelvic bone marrow as FDG uptake greater than the mean of the whole structure can represent underlying cell physiology. This study supports the feasibility of atlas-based approaches published in the literature to contour active bone marrow based on the current definition.

CLINICAL ONCOLOGY (2023)

Article Oncology

Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe

Tiuri E. Kroese, Hanneke W. M. van Laarhoven, Sebastian F. Schoppman, Pieter R. A. J. Deseyne, Eric van Cutsem., Karin Haustermans., Philippe. Nafteux, Melissa Thomas, Radka Obermannova, Hanna R. Mortensen, Marianne Nordsmark, Per Pfeiffer, Anneli Elme, Antoine Adenis, Guillaume Piessen, Christiane J. Bruns, Florian Lordick, Ines Gockel, Markus Moehler, Cihan Gani, Theodore Liakakos, John Reynolds, Alessio G. Morganti, Riccardo Rosati, Carlo Castoro, Francesco Cellini, Domenico D'Ugo, Franco Roviello, Maria Bencivenga, Giovanni de Manzoni, Mark I. van Berge Henegouwen, Maarten C. C. M. Hulshof, Jolanda van Dieren, Marieke Vollebergh, Johanna W. van Sandick, Paul Jeene, Christel T. Muijs, Marije Slingerland, Francine E. M. Voncken, Henk Hartgrink, Geert-Jan Creemers, Maurice J. C. van der Sangen, Grard Nieuwenhuijzen, Maaike Berbee, Marcel Verheij, Bas Wijnhoven, Laurens V. Beerepoot, Nadia H. Mohammad, Stella Mook, Jelle P. Ruurda, Piotr Kolodziejczyk, Wojciech P. Polkowski, Lucjan Wyrwicz, Maria Alsina, Manuel Pera, Tania F. Kanonnikoff, Andres Cervantes, Magnus Nilsson, Stefan Monig, Anna D. Wagner, Matthias Guckenberger, Ewen A. Griffiths, Elizabeth Smyth, George B. Hanna, Sheraz Markar, M. Asif Chaudry, Maria A. Hawkins, Edward Cheong, Richard van Hillegersberg, Peter S. N. van Rossum

Summary: This study aimed to develop a multidisciplinary European consensus statement on the definition, diagnosis and treatment of oligometastatic oesophago-gastric cancer. Through a series of discussions and expert evaluations, a consensus was reached, which can be used for future research in clinical trials.

EUROPEAN JOURNAL OF CANCER (2023)

Article Oncology

Hits and Misses in Novel Pancreatic and Rectal Cancer Treatment Options

Michael D. Chuong, Christopher J. Anker, Michael H. Buckstein, Maria A. Hawkins, Jordan Kharofa, Ann C. Raldow, Nina N. Sanford, Andrzej Wojcieszysnki, Jeffrey R. Olsen

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

Article Gastroenterology & Hepatology

British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma

Simon M. Rushbrook, Timothy James Kendall, Yoh Zen, Raneem Albazaz, Prakash Manoharan, Stephen P. Pereira, Richard Sturgess, Brian R. Davidson, Hassan Z. Malik, Derek Manas, Nigel Heaton, K. Raj Prasad, John Bridgewater, Juan W. Valle, Rebecca Goody, Maria Hawkins, Wendy Prentice, Helen Morement, Martine Walmsley, Shahid A. Khan

Summary: These guidelines commissioned by the British Society of Gastroenterology liver section provide guidance for the diagnosis and management of cholangiocarcinoma (CCA). The writing committee includes a multidisciplinary team of experts and patient/public representatives. Quality of evidence is evaluated using the AGREE II format. The recommendations are meant to guide rather than serve as strict references.
Editorial Material Oncology

Short-Course Radiation Therapy and the RAPIDO Trial: Too Short, Too Soon?

Krishan R. Jethwa, William S. Harmsen, Maria A. Hawkins, Hyun Kim, Nina N. Sanford, Andrzej P. Wojcieszynski, Jeffrey R. Olsen

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

Letter Oncology

Patient-reported outcomes in PROSPECT trial (Alliance N1048) - FOLFOX is not a panacea

Sean M. O'Cathail, Richard Adams, Maria A. Hawkins, David Sebag-Montefiore, Corrie A. M. Marijnen, Emmanouil Fokas

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2023)

Meeting Abstract Oncology

Modeling Survival Outcomes of Immune Checkpoint Inhibitors on Locally Advanced Non-Small Cell Lung Cancer Following Concurrent Chemoradiotherapy

H. T. Huang, M. A. Hawkins, J. D. Fenwick, M. G. Nix

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Article Medicine, Research & Experimental

An app with brief behavioural support to promote physical activity after a cancer diagnosis (APPROACH): study protocol for a pilot randomised controlled trial

P. Lally, N. Miller, A. Roberts, R. J. Beeken, D. M. Greenfield, H. W. W. Potts, N. Counsell, N. Latimer, C. Thomas, L. Smith, J. Gath, F. Kennedy, C. Martin, L. Wyld, A. Fisher

Summary: This trial aims to pilot a theory-driven, app-based intervention that promotes brisk walking among people living with and beyond cancer. The study will investigate the feasibility and acceptability of the intervention and collect data to inform a larger future study.

PILOT AND FEASIBILITY STUDIES (2022)

No Data Available